Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: A prospective cohort study Meeting Abstract


Authors: Lee, Y.; Hui, J. M. H.; Leung, C.; Tsang, C. T. W.; Hui, K.; Tang, P.; Dee, E. C.; Ng, K.; McBride, S.; Nguyen, P. L.; Zhou, J.; Tse, G.; Ng, C. F. A.
Abstract Title: Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: A prospective cohort study
Meeting Title: EAU23 38th Annual Congress
Journal Title: European Urology
Volume: 83
Issue: Suppl. 1
Meeting Dates: 2023 Mar 10-13
Meeting Location: Milan, Italy
ISSN: 0302-2838
Publisher: Elsevier Science, Inc.  
Date Published: 2023-02-01
Start Page: S1738
End Page: S1739
Language: English
ACCESSION: WOS:000991496001490
PROVIDER: wos
DOI: 10.1016/S0302-2838(23)01239-3
Notes: Meeting Abstract: A1201 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Edward Christopher Dee
    253 Dee